How to quickly taper Celexa (citalopram) 40 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Celexa (Citalopram) 40 mg Safely and Quickly

For the fastest safe taper of Celexa 40 mg, reduce by approximately 10% of the original dose per week, which would allow complete discontinuation in about 10 weeks. 1

General Tapering Principles

  • Begin with a reduction of approximately 10% of the original dose per week as a reasonable starting point for a relatively quick taper 1
  • For patients who have been on Celexa for longer periods (≥1 year), a slower taper of 10% per month might be better tolerated 2
  • If withdrawal symptoms become severe, pause tapering and restart when the patient is ready 1
  • Recognize that abrupt discontinuation can be associated with withdrawal symptoms, so tapering is necessary 3

Specific Tapering Schedule for Celexa 40 mg

  • Week 1-2: Reduce from 40 mg to 30 mg daily 1
  • Week 3-4: Reduce to 20 mg daily 1
  • Week 5-6: Reduce to 10 mg daily 1
  • Week 7-8: Reduce to 10 mg every other day 1
  • Week 9-10: Discontinue completely 1

Managing Withdrawal Symptoms

  • Monitor for common withdrawal symptoms after each dose reduction: 4

    • Somatic symptoms: dizziness, light-headedness, nausea, fatigue, flu-like symptoms, sensory disturbances
    • Psychological symptoms: anxiety, agitation, irritability, crying spells
  • If severe withdrawal symptoms occur: 5

    • Return to the previous well-tolerated dose
    • Resume tapering at a slower rate (e.g., 5% reductions instead of 10%)
  • Consider supportive medications for specific symptoms: 1

    • Short-term use of trazodone for anxiety or irritability
    • Sleep hygiene measures and possibly short-term sleep aids for insomnia
    • Appropriate treatments for gastrointestinal symptoms

Special Considerations

  • For patients over 60 years of age, the maximum dose should be limited to 20 mg/day due to expected higher exposures 3
  • Alternating day dosing in the final stages of tapering can be helpful when reaching the smallest available dose 1
  • Withdrawal symptoms typically appear within days of dose reduction and may last 1-3 days per step 1

Potential Pitfalls to Avoid

  • Avoid tapering too quickly, which increases withdrawal risk 1
  • Do not mistake withdrawal symptoms for recurrence of the original condition 1, 4
  • Be aware that protracted withdrawal may occur months after discontinuation, with symptoms including dysphoria, irritability, and insomnia 1
  • Avoid a "one-size-fits-all" approach; be prepared to adjust the tapering schedule based on individual response 6

When to Seek Additional Help

  • If symptoms of the original condition worsen significantly during tapering 1
  • If withdrawal symptoms are intolerable despite slowing the taper 5
  • If new or concerning symptoms emerge that weren't present before 3

Evidence Quality Considerations

Recent research suggests that hyperbolic tapering (making reductions that become smaller as the dose decreases) may be more effective than linear tapering for minimizing withdrawal symptoms 7. However, the 10% reduction approach provides a practical framework that balances speed with safety for most patients 8.

References

Guideline

Tapering and Stopping Cymbalta (Duloxetine) Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Discontinuing antidepressants: Pearls and pitfalls.

Cleveland Clinic journal of medicine, 2022

Guideline

Tapering Aripiprazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antidepressant Tapering Is Not Routine But Could Be.

Journal of the American Board of Family Medicine : JABFM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.